Results
7
Companies which can be considered undervalued when accounting for expected future growth (PEG under 0.8)
7 companies
Clariant
Market Cap: CHF 2.7b
Develops, manufactures, distributes, and sells specialty chemicals in Switzerland, Europe, the Middle East, Africa, the United States, and the Asia Pacific.
CLN
CHF 8.17
7D
0.3%
1Y
-34.0%
Cosmo Pharmaceuticals
Market Cap: CHF 1.1b
Focuses on the development and commercialization products for gastroenterology, dermatology, and healthtech worldwide.
COPN
CHF 68.00
7D
3.2%
1Y
-13.0%
Vetropack Holding
Market Cap: CHF 489.7m
Provides glass packaging products for the food and beverage industry.
VETN
CHF 24.70
7D
-0.8%
1Y
-20.6%
Phoenix Mecano
Market Cap: CHF 398.1m
Manufactures and sells components for industrial customers worldwide.
PMN
CHF 430.00
7D
0%
1Y
0.5%
Newron Pharmaceuticals
Market Cap: CHF 178.7m
A biopharmaceutical company, discovers and develops novel therapies for patients with diseases of the central and peripheral nervous system in Italy and the United States.
NWRN
CHF 8.95
7D
-5.6%
1Y
8.2%
StarragTornos Group
Market Cap: CHF 174.8m
Develops, manufactures, and distributes precision machine tools for milling, turning, boring, grinding, and machining of work pieces of metal, composite materials, and ceramics.
STGN
CHF 32.00
7D
2.2%
1Y
-30.4%
lastminute.com
Market Cap: CHF 160.4m
Operates in the online travel industry providing dynamic holiday packages in Italy, Spain, the United Kingdom, France, Germany, and internationally.
LMN
CHF 15.05
7D
-1.6%
1Y
-19.9%